TEON THERAPEUTICS
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.
TEON THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.teontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 486 1902
Email Addresses:
[email protected]
Total Funding:
37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress AJAX Libraries API Cloudflare WordPress 6.0 Cloudflare SSL Typekit
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oceanpine Capital
Oceanpine Capital investment in Series A - Teon Therapeutics
Oriental Fortune Capital
Oriental Fortune Capital investment in Series A - Teon Therapeutics
Oriza Ventures
Oriza Ventures investment in Series A - Teon Therapeutics
Kaitai Capital
Kaitai Capital investment in Series A - Teon Therapeutics
Lifespan Investments
Lifespan Investments investment in Series A - Teon Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Teon Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Seed Round - Teon Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-03-08 | Teon Therapeutics Names Serge Messerlian as CEO |
Official Site Inspections
http://www.teontherapeutics.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago